A5035579250- Diabetes Management and Research
- Diabetes Management and Education
- Diabetes and associated disorders
- Diabetes Treatment and Management
- Mobile Health and mHealth Applications
- Chronic Disease Management Strategies
- Pancreatic function and diabetes
- Medication Adherence and Compliance
- Adolescent and Pediatric Healthcare
- Cardiovascular Health and Risk Factors
- Gestational Diabetes Research and Management
- Food Security and Health in Diverse Populations
- COVID-19 Clinical Research Studies
- Health, Environment, Cognitive Aging
- Pharmaceutical Practices and Patient Outcomes
- Health disparities and outcomes
- Cardiovascular Issues in Pregnancy
- Maternal and Perinatal Health Interventions
- Congenital Heart Disease Studies
- Obesity and Health Practices
- Primary Care and Health Outcomes
- Southeast Asian Sociopolitical Studies
- Childhood Cancer Survivors' Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
Montefiore Medical Center
2021-2024
Albert Einstein College of Medicine
2020-2024
Kasturba Hospital
2021-2024
The Bronx Defenders
2020-2024
Santosh University
2024
JSS Academy of Higher Education and Research
2023
Yeshiva University
2022
Jehangir Hospital
2021
O. P. Jindal Global University
2020
University of Pennsylvania
2015-2020
Abstract Context Minority young adults (YA) currently represent the largest growing population with type 1 diabetes (T1D) and experience very poor outcomes. Modifiable drivers of disparities need to be identified, but are not well-studied. Objective To describe racial-ethnic among YA T1D identify glycemic disparity other than socioeconomic status (SES). Design Cross-sectional multicenter collection patient chart-reported variables, including SES, social determinants health, diabetes-specific...
Despite documented benefits of diabetes technology in managing type 1 diabetes, inequities persist the use these devices. Provider bias may be a driver inequities, but evidence is limited. Therefore, we aimed to examine role race/ethnicity and insurance-mediated provider implicit recommending technology.
Importance There is a need for additional treatment options people with type 2 diabetes treated insulin. Given the limited data on use of automated insulin delivery (AID) systems in diabetes, studies evaluating their safety and efficacy are important. Objective To evaluate association AID hemoglobin A 1c (HbA ) levels diverse cohort adults diabetes. Design, Setting, Participants This single-arm prospective trial was conducted at 21 clinical centers United States among individuals aged 18 to...
Background: Recent studies highlight racial-ethnic disparities in insulin pump and continuous glucose monitor (CGM) use people with type 1 diabetes (T1D), but drivers of remain poorly understood beyond socioeconomic status (SES). Methods: We recruited a diverse sample young adults (YA) T1D from six centers across the United States, enrolling equal numbers non-Hispanic (NH) White, NH Black, Hispanic YA. used multivariate logistic regression to examine what extent SES, demographics, health...
Health disparities in the clinical presentation and outcomes among youth with type 1 diabetes exist. Long-term glycemic control patterns racially/ethnically diverse are not well described.To model common trajectories of hemoglobin A1c (HbA1c) test how trajectory group membership varies by race/ethnicity.Longitudinal cohort study conducted 5 US locations. The analysis included data from 1313 youths (aged <20 years) newly diagnosed 2002 through 2005 SEARCH for Diabetes Youth (mean [SD] age at...
OBJECTIVE The use of remote real-time continuous glucose monitoring (CGM) in the hospital has rapidly emerged to preserve personal protective equipment and reduce potential exposures during coronavirus disease 2019 (COVID-19). RESEARCH DESIGN AND METHODS We linked a hybrid CGM point-of-care (POC) testing protocol computerized decision support system for insulin infusion integrated validation sensor values into electronic health record. report our proof-of-concept experience COVID-19...
We examined whether diabetic ketoacidosis (DKA), a serious complication of type 1 diabetes (T1D) was more prevalent among Non-Hispanic (NH) Black and Hispanic patients with T1D laboratory-confirmed coronavirus disease 2019 (COVID-19) compared NH Whites.This is cross-sectional study COVID-19 from 52 clinical sites in the United States, data were collected April to August 2020. distribution patient factors DKA events across White, Black, race/ethnicity groups. Multivariable logistic regression...
Diabetes mellitus is associated with increased COVID-19 morbidity and mortality, but there are few data focusing on outcomes in people type 1 diabetes.The objective of this study was to analyze characteristics adults diabetes for associations hospitalization.An observational multisite cross-sectional performed. care providers answered a 33-item questionnaire regarding demographics, symptoms, diabetes- COVID-19-related outcomes. Descriptive statistics were used describe the population,...
Background: Racial-ethnic disparities in diabetes technology use are well documented young adults (YA) with type 1 (T1D), but modifiable targets for intervention still need to be identified. Our objective was explore YA perspectives on access and support routine clinical care. Materials Methods: Participants were T1D of Hispanic or non-Hispanic Black race-ethnicity from pediatric adult endocrinology clinics the Bronx, NY. We conducted semistructured individual interviews how health care...
Phaeochromocytoma crisis is a life-threatening emergency that may be undiagnosed because of its numerous, nonspecific manifestations. We analysed, retrospectively, the presentation, management and outcome patients who were admitted to our institution with phaeochromocytoma crises over 5-year period.Five (two males, three females; mean age 34.6 years, range 19-51 years) presented as emergencies requiring intensive care, multiple non-specific manifestations previously pheochromocytoma,...
Despite the benefits of continuous glucose monitoring (CGM), there is lower use this technology among non-Hispanic Black and Hispanic people with type 1 diabetes compared their White counterparts. The T1D Exchange Quality Improvement Collaborative recruited five endocrinology centers to pilot an equity-focused quality improvement (QI) study reduce racial inequities in CGM use. used rapid QI cycles test expand interventions such as provider bias training, translation materials, provision...
Abstract Context Cardiovascular disease (CVD) is a major cause of mortality in adults with type 1 diabetes. Objective We prospectively evaluated CVD risk factors large, contemporary cohort diabetes living the United States. Design Observational study and over median 5.3 years. Setting The T1D Exchange clinic network. Patients Adults (age ≥ 18 years) without known diagnosed before or at enrollment. Main Outcome Measure Associations between incident were assessed by multivariable logistic...
The Glycemia Risk Index (GRI) was introduced as a single value derived from the ambulatory glucose profile that identifies patients who need attention. This study describes participants in each of five GRI zones and examines percentage variation scores is explained by sociodemographic clinical variables among diverse adults with type 1 diabetes.
Standard treatment of hypoglycemia is oral carbohydrate, but it often results in hyperglycemia and entails extra caloric intake. To evaluate low-dose glucagon to treat mild ambulatory adults with type 1 diabetes (T1D). Randomized crossover trial (two 3-week periods). Five U.S. clinics. Twenty T1D using an insulin pump continuous glucose monitor (CGM) experiencing frequent hypoglycemia. Nonaqueous mini-dose (MDG) (150 µg) nonsevere Successful was defined as blood (BG) ≥50 mg/dL 15 minutes ≥70...
Continuous glucose monitoring (CGM) is associated with improved outcomes in type 1 diabetes, but racial-ethnic disparities exist use. We were interested examining whether addressing structural health care barriers would change provider prescribing behaviors to make CGM access more equitable.
Many adults with diabetes do not reach optimal glycemic targets, and, despite advances in management, technology use remains significantly lower racial/ethnic minority groups. This study aimed to identify factors associated achieving the recommended A1C target of <7% using data on 12,035 type 1 from 15 centers participating T1D Exchange Quality Improvement Collaborative. Individuals attaining were more likely be older, White, have private health insurance, and less report depressive symptoms...
<sec> <title>BACKGROUND</title> Inequity in diabetes technology use among Black and Hispanic youth with type 1 (T1D) persists. Community health workers (CHW) can address social clinical barriers to device use, but more information is needed on clinicians’ perceptions inform a CHW model for T1D. </sec> <title>OBJECTIVE</title> This study aimed identify co-create solutions inequity clinicians of <title>METHODS</title> Using human-centered design, we conducted virtual workshops 17 participants...
Approximately 1.6 million people in the United States have type 1 diabetes (T1D).1 The incidence of T1D is increasing across all populations, most significantly among Hispanic and non-Hispanic Black (NHB) patients.2, 3 Unfortunately, widespread inequities exist health outcomes patients with States.4-7 In 2016, Exchange Quality Improvement Collaborative (T1DX-QI) was established.8 T1DX-QI a learning network9 over 40 centers States. Participating use continuous quality improvement (QI)...
Background: Racial–ethnic inequity in type 1 diabetes technology use is well documented and contributes to disparities glycemic long-term outcomes. However, solutions address remain sparse lack stakeholder input. Methods: We employed user-centered design principles conduct workshop sessions with multidisciplinary panels of stakeholders, building off our prior study highlighting patient-identified barriers proposed solutions. Stakeholders were convened review findings co-create interventions...